# A Study of the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Doses of RTA 901 in Healthy Adults

> **NCT02666963** · PHASE1 · COMPLETED · sponsor: **Biogen** · enrollment: 78 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** RTA 901 Capsules, 10 or 40 mg
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02666963
- **Lead sponsor:** Biogen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-01-01
- **Primary completion:** 2017-07-23
- **Final completion:** 2017-07-23
- **Target enrollment:** 78 (ACTUAL)
- **Last updated:** 2025-05-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02666963

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02666963, "A Study of the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Doses of RTA 901 in Healthy Adults". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02666963. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*